Zoonotic Brazilian Vaccinia virus: from field to therapy

Antiviral Res. 2011 Nov;92(2):150-63. doi: 10.1016/j.antiviral.2011.08.018. Epub 2011 Aug 27.

Abstract

Vaccinia virus (VACV), the prototype species of the Orthopoxvirus (OPV) genus, causes an occupational zoonotic disease in Brazil that is primarily associated with the handling of infected dairy cattle. Cattle and human outbreaks have been described in southeastern Brazil since 1999 and have now occurred in almost half of the territory. Phylogenetic studies have shown high levels of polymorphisms among isolated VACVs, which indicate the existence of at least two genetically divergent clades; this has also been proven in virulence assays in a mouse model system. In humans, VACV infection is characterized by skin lesions, primarily on the hands, accompanied by systemic symptoms such as fever, myalgia, headache and lymphadenopathy. In this review, we will discuss the virological, epidemiological, ecological and clinical aspects of VACV infection, its diagnosis and compounds that potentially could be used for the treatment of severe cases.

Publication types

  • Review

MeSH terms

  • Animals
  • Brazil / epidemiology
  • Cattle
  • Cattle Diseases / epidemiology*
  • Cattle Diseases / pathology
  • Cattle Diseases / virology
  • Humans
  • Molecular Epidemiology
  • Occupational Diseases / epidemiology*
  • Occupational Diseases / pathology
  • Occupational Diseases / virology
  • Phylogeny
  • Polymorphism, Genetic
  • Vaccinia / epidemiology*
  • Vaccinia / pathology
  • Vaccinia / veterinary*
  • Vaccinia / virology
  • Vaccinia virus / classification
  • Vaccinia virus / genetics
  • Vaccinia virus / isolation & purification*
  • Zoonoses / epidemiology*
  • Zoonoses / virology